Prescription Audit in OPD of NABH & JCI Approved Hospital in Capital Territory of India

NCT05729412 | Completed

• 1 other identifier: MAX/IEC/2022/NOV/PA01
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Aim of the study: The aim of the study is to evaluate the quality of the prescription provided to the outpatient. Need of study: For the promotion of the good clinical practice To improve the efficiency of the multidisciplinary team in the healthcare To utilize resources to provide better patient care To improve quality standards and quality of care For implication of professional practices To identify and eliminate deficient practice Objectives:

• To select the patient based on inclusion and exclusion criteria
• To collect the information from OP's prescription
• To identify prescribing errors and medication error
• To study the management of good prescription Study Sites: Max Super Speciality Hospital, Saket, New Delhi (INDIA) Study Design: Observational cohort study Study Duration: 1 month (November 2022)

Conditions

Quality of Life

Keywords

Medical Audit; Prescription Audit; Gender difference

Outcome Measures

Primary Outcomes (1)

• Percentage of prescription

  Data is available sufficient

  November 01, 2022 to November 30, 2022

Study Arms (3)

Compliance

Prescription is filled for specific parameters

Other: Mentioned

Non-compliance

Prescription is not filled for specific parameters

Other: Mentioned

Not available - NA

Data not available

Other: Mentioned

Interventions

Mentioned OTHER

If prescription is properly filled for specific details than it is compliance

Also known as: Prescription is properly filled

Compliance; Non-compliance; Not available - NA

Eligibility Criteria

• Age: 18 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Any patient prescription which is randomly picked during study period

You may qualify if:

• Participants who are willing to participate.
• Participants who are attending in the out-patient department.
• Participants reported during the study period.
• Participants who have a prescription which is legible and complete.

You may not qualify if:

• Participants who are unwilling to provide the required information.
• Participants who are not attending the out-patient department.
• Participants whose prescription is not legible and competent

Sponsors & Collaborators

• Kakatiya University: lead

Study Sites (1)

Max Super Speciality Hospital

New Delhi, National Capital Territory of Delhi, 110017, India

Location

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Clinical Pharmacy Department

Study Record Dates

• First Submitted: January 31, 2023
• First Posted: February 15, 2023
• Study Start: November 1, 2022
• Primary Completion: January 1, 2023
• Study Completion: January 1, 2023
• Last Updated: June 7, 2023

Record last verified: 2023-06

Locations

IN (1)